Cargando…

Anti-cancer Potential of Captopril and Botulinum Toxin Type-A and Associated p53 Gene Apototic Stimulating Activity

Mutational inactivation of p53 is a key player in the development of human cancer. Thus, retrieving the tumor suppressor activity of p53 gene is considered a novel strategy in cancer therapy. Current study aimed to investigate the anti-cancer potentials of botulinum toxin type-A (BTX-A) and captopri...

Descripción completa

Detalles Bibliográficos
Autor principal:	Shebl, Rania Ibrahim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059072/ https://www.ncbi.nlm.nih.gov/pubmed/32184862 http://dx.doi.org/10.22037/ijpr.2019.1100800

Ejemplares similares

BOTULINUM TOXIN
por: Nigam, P K, et al.
Publicado: (2010)

Correction: Čapek, P., et al. Sensing the Deadliest Toxin: Technologies for Botulinum Neurotoxin Detection. Toxins 2010, 2, 24-53
por: Čapek, Petr, et al.
Publicado: (2010)

Headache and botulinum toxin
por: Porta, M., et al.
Publicado: (2005)

Immunogenicity of botulinum toxins
por: Naumann, Markus, et al.
Publicado: (2012)

Diffusion of Botulinum Toxins
por: Brodsky, Matthew A., et al.
Publicado: (2012)

Immunogenicity of botulinum toxin
por: Wee, Syeo Young, et al.
Publicado: (2022)

Use of botulinum toxin type a in psychiatry - new perspectives and future potential
por: Viegas, F. Gonçalves, et al.
Publicado: (2021)

Hyaluronic Acid Present in the Tumor Microenvironment Can Negate the Pro-apototic Effect of a Recombinant Fragment of Human Surfactant Protein D on Breast Cancer Cells
por: Murugaiah, Valarmathy, et al.
Publicado: (2020)

Immunogenicity of Botulinum Toxin Formulations: Potential Therapeutic Implications
por: Carr, Warner W., et al.
Publicado: (2021)

Botulinum toxin in gastric submucosa reduces stimulated HCl production in rats
por: Runfola, Matteo, et al.
Publicado: (2003)

Botulinum toxin treatment for hypersalivation in anti‐NMDA receptor encephalitis
por: Jun, Jin‐Sun, et al.
Publicado: (2017)

Pharmacokinetics of Human Recombinant Anti-Botulinum Toxin Antibodies in Rats
por: Espinoza, Yero, et al.
Publicado: (2019)

Cosmetic use of botulinum toxin type A in the elderly
por: Cheng, Christine M
Publicado: (2007)

Botulinum toxin type-A in the treatment of glabellar lines
por: Winter, Leslie, et al.
Publicado: (2009)

Botulinum toxin type A for the management of glabellar rhytids
por: Tremaine, Anne Marie, et al.
Publicado: (2010)

Use of botulinum toxin type A in Frey's syndrome
por: Gualberto, Gustavo Vieira, et al.
Publicado: (2017)

Mechanisms of Botulinum Toxin Type A Action on Pain
por: Matak, Ivica, et al.
Publicado: (2019)

Toxin yet not toxic: Botulinum toxin in dentistry
por: Archana, M.S.
Publicado: (2016)

Toxic potential of botulinum toxin type A on senescence in a Drosophila melanogaster model
por: Fooladvand, Farnoosh, et al.
Publicado: (2021)

The Action of Botulinum Toxin A on the Sternocleidomastoid Muscle: An Experimental Study on Rats
por: Vampertzis, Themistoklis, et al.
Publicado: (2022)

Controversy: Botulinum Toxin in Pregnancy
por: Paul, Munish
Publicado: (2009)

Botulinum toxin: The Midas touch
por: Shilpa, P. S., et al.
Publicado: (2014)

Wound Modulation with Botulinum Toxin
por: Malik, Archana, et al.
Publicado: (2016)

Botulinum Toxin in the Treatment of Headache
por: Becker, Werner J.
Publicado: (2020)

Botulinum toxin therapy of dystonia
por: Dressler, Dirk, et al.
Publicado: (2020)

Botulinum Toxin for Scalp Dysesthesia
por: Phan, Kevin, et al.
Publicado: (2022)

Treatment of Depression with Botulinum Toxin
por: Wollmer, Marc Axel, et al.
Publicado: (2022)

Emerging treatments for overactive bladder: clinical potential of botulinum toxins
por: Tincello, Douglas G, et al.
Publicado: (2014)

Botulinum Toxin, a Drug with Potential Interest for Dentists—An Introduction
por: Bakke, Merete
Publicado: (2022)

The Multispecialty Toxin: A Literature Review of Botulinum Toxin
por: Bach, Karen, et al.
Publicado: (2022)

Botulinum toxin type A in the treatment of patients with cervical dystonia
por: Brashear, Allison
Publicado: (2009)

Elevation of the Corner of the Mouth Using Botulinum Toxin Type A
por: Goldman, Alberto, et al.
Publicado: (2010)

Effect of botulinum toxin type-A in patients with focal spasticity
por: Selimoglu, Esra, et al.
Publicado: (2015)

Botulinum toxin injection in the patients with Duane syndrome type 1
por: Ameri, Ahmad, et al.
Publicado: (2016)

Scientific review of the aesthetic uses of botulinum toxin type A
por: Park, Mee Young, et al.
Publicado: (2021)

THE EFFECT OF BOTULINUM TOXIN TYPE A IN PATIENTS WITH ESSENTIAL BLEPHAROSPASM
por: Gaćina, Klara, et al.
Publicado: (2022)

Spectrophotometric Determination of Captopril and Penicillamine through the Use of Ligand Exchange Complexation Reactions
por: Belal, Saied, et al.
Publicado: (2011)

Economics of botulinum toxin therapy: influence of the abobotulinumtoxinA package size on the costs of botulinum toxin therapy
por: Dressler, Dirk, et al.
Publicado: (2017)

Intradetrusor botulinum toxin type A in refractory overactive bladder: A potential future treatment
por: Mahajan, Rajiv, et al.
Publicado: (2011)

Botulinum toxin injections for blepharospasm prior to ocular surgeries
por: Okumus, Seydi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_utiptimuce0cd9d0elesvb054n